Hilltelligence markHilltelligence
Bills/H.R. 679119th Congress

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

House: Referred
Cosponsors
18
Introduced
2025-01-23
Last action
2025-01-23

Referred to the House Committee on Energy and Commerce.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the House Committee on Energy and Commerce.

  2. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Legislative subjects

AbortionDrug safety, medical device, and laboratory regulationDrug therapyPrescription drugs

Sign in to view Hilltelligence’s potential-cosponsor analysis.